STAGE III BREAST CANCER
Clinical trials for STAGE III BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE III BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE III BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to wipe out HER2 low breast cancer before surgery
Disease control Recruiting nowThis study tests a drug called trastuzumab deruxtecan, which delivers chemotherapy directly to cancer cells with low levels of HER2, either alone or with anastrozole (a hormone blocker). The goal is to see if these treatments can eliminate all signs of cancer before surgery in pe…
Matched conditions: STAGE III BREAST CANCER
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 17, 2026 00:46 UTC
-
New scan may spot hidden breast cancer spread early
Diagnosis Recruiting nowThis study is testing whether a special PET scan called FES PET/CT can better detect cancer that has spread to distant parts of the body in people with a certain type of stage III breast cancer. The cancer must be low-grade and estrogen receptor-positive. About 85 adults will rec…
Matched conditions: STAGE III BREAST CANCER
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Diagnosis
Last updated May 17, 2026 00:50 UTC
-
Home workouts may help older breast cancer patients stay strong through chemo
Symptom relief Recruiting nowThis study looks at whether a telehealth exercise program with protein support can help women aged 65 and older with breast cancer complete their full chemotherapy schedule. Participants will either do resistance exercises at home or receive health education. The goal is to see i…
Matched conditions: STAGE III BREAST CANCER
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
Personalized exercise may protect heart and mind during cancer treatment
Symptom relief Recruiting nowThis study tests whether a tailored physical activity program can help preserve exercise capacity, heart function, memory, and quality of life in adults (ages 18-85) with Hodgkin or non-Hodgkin lymphoma or stage I-III breast cancer who are undergoing chemotherapy or other cardiot…
Matched conditions: STAGE III BREAST CANCER
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC
-
Can a vaginal moisturizer ease breast cancer side effects?
Symptom relief Recruiting nowThis study tests whether Revaree Plus, a vaginal moisturizer, can improve vaginal dryness in women with hormone-receptor-positive breast cancer. About 60 participants who have completed primary cancer therapy or are on maintenance treatment will use the product for 8 weeks. The g…
Matched conditions: STAGE III BREAST CANCER
Phase: PHASE4 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated May 12, 2026 13:39 UTC
-
Disappearing ink could make radiation easier for breast cancer patients
Symptom relief Recruiting nowThis study tests a new tattoo ink called Magic Ink that fades away over time, used to mark the exact spot for daily radiation in women with breast cancer. About 30 participants will get the Magic Ink instead of standard permanent ink. Researchers want to see if it is safe and sti…
Matched conditions: STAGE III BREAST CANCER
Phase: NA • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Symptom relief
Last updated May 08, 2026 12:01 UTC
-
Blood test may predict chemo success in breast cancer
Knowledge-focused Recruiting nowThis study looks at whether a blood test that measures circulating tumor DNA (ctDNA) can help predict how well breast cancer responds to chemotherapy before surgery. Researchers will take blood samples from 125 women with stage II or III breast cancer before, during, and after tr…
Matched conditions: STAGE III BREAST CANCER
Sponsor: Gene Solutions • Aim: Knowledge-focused
Last updated May 17, 2026 00:46 UTC